Type 1 diabetes patients on glucagon show increased satiety

08/22/2013 | Healio

A study in The Journal of Clinical Endocrinology & Metabolism revealed glucagon helped increase satiety in patients with type 1 diabetes and healthy lean participants. However, obese but otherwise healthy participants did not attain such benefits. Researchers said that while therapeutic agents that affect glucagon are considered "a promising avenue for research," the study indicates that treatment with glucagon might not be effective for reducing food consumption in obese people.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC